ImmunityBio stock: Friday evening quote from Lang & Schwarz

Published on 11/06/2026 at 22:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The biotechnology company was quoted in Friday evening trading. Investors can follow the latest ImmunityBio stock quote in euros.

ImmunityBio stock remains in focus

ImmunityBio operates in the healthcare and biotechnology sectors.
The company develops therapies and vaccines targeting cancer and infectious diseases.

IBRX, US45256X1037, Illustration mit AI erstellt.

Friday Evening Quote

ImmunityBio stock traded at 7.69 euros on Lang & Schwarz at 10:48 p.m. CET on Friday, November 6, 2026; the real-time quote of ImmunityBio stock is available here.

ImmunityBio is a clinical-stage biotechnology company focused on therapies and vaccines for cancer and infectious diseases. Its development platform includes immunotherapy and cell-therapy approaches.

Clinical Development Focus

The company is advancing investigational treatments for liquid and solid tumors, including bladder, pancreatic and lung cancers. Several candidates are in Phase II or Phase III development.

ImmunityBio stock facts

Company: ImmunityBio, Inc.
ISIN: US45256X1037
Ticker: IBRX
Sector: Healthcare
Industry: Biotechnology
Lang & Schwarz quote: 7.69 euros on Friday, November 6, 2026, at 10:48 p.m. CET

The broader US equity market is tracked through the S&P 500.

More news and analyses on ImmunityBio stock.